Related Experiment Video
Updated: Sep 13, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
[Endometrial Cancer: From Clinical Diagnosis to Treatment Strategy]
Marc Baron1, Benoît Resch1, Hélène Chiavelli2
1Institut de Chirurgie de la Femme, 19 rue de Lessard, 76100 Rouen, France.
Abstract:
Uterine cancer, or endometrial cancer, is the most common gynecological cancer after breast cancer. It primarily affects postmenopausal women, and abnormal vaginal bleeding is its main warning sign. Risk factors include age, obesity, and non-insulin-dependent diabetes. The prognosis depends on the stage at diagnosis, the histological type, and molecular factors included in the 2023 International Federation of Gynecology and Obstetrics classification, which helps guide treatment decisions between surgery, radiation therapy, and chemotherapy.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistent Cancers
